COLUMBUS, Ohio — Two Ohio bills that may have effects on abortion medication and access were considered in separate Ohio House committees this week.

Opponents of a bill to further regulate medication that could include abortion drugs deeply criticized a study used by supporters of the measure, and argued about the unintended consequences held in the legislation.

Ohio State University epidemiology professor Dr. Alison Norris said a study on the safety of abortion drug mifepristone cited by supporters of the bill to prove the dangers of the drug was “deeply flawed,” causing concern about the types of evidence sources the bill would allow the Ohio Department of Health to use in determining drug risks.

The study counted the number of emergency room visits for any reason as part of the “adve

See Full Page